Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy manufacturing
Pharma
AZ tacks on $2B to its investment in US manufacturing, R&D
Citing a rosy view of the U.S. economy’s potential for growth, AstraZeneca is boosting its investment in local manufacturing and R&D by $2 billion.
Fraiser Kansteiner
Nov 12, 2024 10:10am
AGC Bio embarks on turnaround strategy under new CEO
Nov 7, 2024 10:10am
Canadian CDMO OmniaBio debuts new cell and gene therapy facility
Oct 17, 2024 9:25am
WuXi service providers eye asset sales amid BIOSECURE threat: FT
Oct 3, 2024 9:47am
Aspen Neuroscience levels up in-house cell therapy production
Oct 2, 2024 8:15am
Legend strikes cell therapy automation pact with Multiply Labs
Sep 24, 2024 9:00am
